Covered recipient · General Payments record
ADRIANA SARAH KANE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2023
$236.29
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.60 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $60.38 | 2 |
| Acerta Pharma LLC | $36.73 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.76 | 1 |
| Lilly USA, LLC | $29.32 | 1 |
| Grifols USA, LLC | $25.14 | 1 |
| Axsome Therapeutics, Inc. | $24.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $18.81 | 07/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011612641 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.92 | 10/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011587603 | CMS |
| Axsome Therapeutics, Inc. | $24.27 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056227895 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.76 | 11/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996716213 | CMS |
| Grifols USA, LLC | $25.14 | 09/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011887061 | CMS |
| Lilly USA, LLC | $29.32 | 07/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032621271 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.23 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055914733 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.15 | 11/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055914740 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.